Patent: 4,364,861
✉ Email this page to a colleague
Summary for Patent: 4,364,861
| Title: | Blood-coagulation-promoting products and methods of preparing them |
| Abstract: | Blood-coagulation-promoting products substantially free of thrombin are prepared from human blood plasma by contacting a human blood plasma fraction containing coagulation Factors II, VII, IX and X with an anion exchanger to adsorb the coagulation Factors, which are subsequently eluted from the anion exchanger. The eluate is treated to generate a substance having Factor VIII Inhibitor Bypassing Activity and being substantially free of thrombin, and activated Factor X. |
| Inventor(s): | Mitra; Gautam (Kensington, CA), Coan; Michael H. (El Cerrito, CA), Wada; Shohachi (Oakland, CA) |
| Assignee: | Cutter Laboratories, Inc. (Berkeley, CA) |
| Application Number: | 06/153,341 |
| Patent Claims: | see list of patent claims |
Details for Patent 4,364,861
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.s.a., Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | December 21, 1979 | ⤷ Start Trial | 2000-05-27 |
| Takeda Pharmaceuticals U.s.a., Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | July 31, 2000 | ⤷ Start Trial | 2000-05-27 |
| Takeda Pharmaceuticals U.s.a., Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | August 11, 2005 | ⤷ Start Trial | 2000-05-27 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
